CABA
Price
$2.37
Change
+$0.06 (+2.60%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
215.86M
46 days until earnings call
DTCFF
Price
$0.55
Change
+$0.02 (+3.77%)
Updated
Sep 24 closing price
Capitalization
31.11M
Interact to see
Advertisement

CABA vs DTCFF

Header iconCABA vs DTCFF Comparison
Open Charts CABA vs DTCFFBanner chart's image
Cabaletta Bio
Price$2.37
Change+$0.06 (+2.60%)
Volume$51.56K
Capitalization215.86M
DEFENCE THERAPEUTICS
Price$0.55
Change+$0.02 (+3.77%)
Volume$900
Capitalization31.11M
CABA vs DTCFF Comparison Chart in %
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DTCFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. DTCFF commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and DTCFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CABA: $2.36 vs. DTCFF: $0.55)
Brand notoriety: CABA and DTCFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 126% vs. DTCFF: 30%
Market capitalization -- CABA: $215.86M vs. DTCFF: $31.11M
CABA [@Biotechnology] is valued at $215.86M. DTCFF’s [@Biotechnology] market capitalization is $31.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileDTCFF’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • DTCFF’s FA Score: 0 green, 5 red.
According to our system of comparison, CABA is a better buy in the long-term than DTCFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 6 TA indicator(s) are bullish while DTCFF’s TA Score has 5 bullish TA indicator(s).

  • CABA’s TA Score: 6 bullish, 4 bearish.
  • DTCFF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CABA is a better buy in the short-term than DTCFF.

Price Growth

CABA (@Biotechnology) experienced а +7.76% price change this week, while DTCFF (@Biotechnology) price change was +3.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

CABA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CABA($216M) has a higher market cap than DTCFF($31.1M). DTCFF YTD gains are higher at: 39.723 vs. CABA (4.401). DTCFF has higher annual earnings (EBITDA): -3.16M vs. CABA (-140.83M). CABA has more cash in the bank: 195M vs. DTCFF (2.08M). DTCFF has less debt than CABA: DTCFF (1.39M) vs CABA (24.9M). CABA (0) and DTCFF (0) have equivalent revenues.
CABADTCFFCABA / DTCFF
Capitalization216M31.1M695%
EBITDA-140.83M-3.16M4,456%
Gain YTD4.40139.72311%
P/E RatioN/AN/A-
Revenue00-
Total Cash195M2.08M9,375%
Total Debt24.9M1.39M1,788%
FUNDAMENTALS RATINGS
CABA: Fundamental Ratings
CABA
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABADTCFF
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
52%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
46%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 30 days ago
65%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
60%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DTCFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVHSY3.15N/A
N/A
CABLEVISION HLDGS SA
NRILY38.56N/A
N/A
Nomura Research Institute Ltd.
PMOIF3.00N/A
N/A
Harbour Energy Plc
AIXN0.15N/A
N/A
AiXin Life International, Inc.
THBRF1.07N/A
N/A
Thunderbird Entertainment Group Inc.

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with IPSC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+2.59%
IPSC - CABA
52%
Loosely correlated
+4.41%
GBIO - CABA
46%
Loosely correlated
+5.16%
ARWR - CABA
46%
Loosely correlated
+3.58%
KYTX - CABA
45%
Loosely correlated
-4.25%
ARCT - CABA
45%
Loosely correlated
+9.11%
More

DTCFF and

Correlation & Price change

A.I.dvisor tells us that DTCFF and BRCTF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DTCFF and BRCTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTCFF
1D Price
Change %
DTCFF100%
N/A
BRCTF - DTCFF
25%
Poorly correlated
N/A
CNSP - DTCFF
25%
Poorly correlated
+2.89%
NEVPF - DTCFF
22%
Poorly correlated
N/A
CABA - DTCFF
21%
Poorly correlated
+2.59%
UNCY - DTCFF
20%
Poorly correlated
+7.58%
More